Hansa Biopharma AB

NEW
LTS:0RC7 (Sweden)   Ordinary Shares
kr 33.18 +0.43 (+1.31%) Jul 21
At Loss
Market Cap:
kr 3.33B ($ 343.10M)
Enterprise V:
kr 3.79B ($ 391.10M)
Volume:
5.91K
Avg Vol (2M):
3.68K
Trade In:
Volume:
5.91K
At Loss

Hansa Biopharma AB (LTS:0RC7) Dividend

Hansa Biopharma AB (LTS:0RC7) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -23.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0RC7 Dividend

Does Hansa Biopharma AB (LTS:0RC7) pay a dividend?

Hansa Biopharma AB (LTS:0RC7) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Hansa Biopharma AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Hansa Biopharma AB has returned capital to shareholders via buybacks at a rate of -23.9% over the past 3 years.

What are dividend-paying alternatives to Hansa Biopharma AB?

For dividend-paying alternatives in Hansa Biopharma AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.